Extending survival in meningioma patients with innovative radiopharmaceutical therapy

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor.

Bellerophon Therapeutics lets almost all employees go, looks for deals in wake of PhIII flop

Less than a month after admitting failure in a highly anticipated trial of its only program, Bellerophon Therapeutics is waving the white flag. The biotech’s

July 1, 2023

Abbott receives FDA OK for over-the-counter glucose monitor

Dive Brief: Abbott received clearance from the Food and Drug Administration for an over-the-counter glucose monitor. The device, called Lingo, first debuted in the U.K.

June 3, 2024

Novo Nordisk’s longstanding GLP-1 reduced BMI by 7% in children in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.